acetylglucosamine has been researched along with Pneumonia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bigioni, I; De Berardis, B; Marchetti, M; Mariano, A; Scotto d'Abusco, A; Superti, F | 1 |
| Bordin, AI; Cohen, ND; Cywes-Bentley, C; Kahn, SK; Pier, GB; Ramirez-Cortez, S; Schuckert, AE; Vinacur, M | 1 |
| Eguchi-Tsuda, M; Inoue, H; Kan-O, K; Kita, Y; Matsumoto, K; Matsumoto, T; Moriwaki, A; Nagasawa, H; Nakanishi, Y; Nakano, T; Noda, N; Sakuda, S; Sato, Y; Shimizu, T | 1 |
1 trial(s) available for acetylglucosamine and Pneumonia
| Article | Year |
|---|---|
Serum Antibody Activity against Poly-
Topics: Acetylglucosamine; Actinomycetales Infections; Animals; Animals, Newborn; Antibodies, Bacterial; Bacterial Vaccines; Female; Horse Diseases; Horses; Male; Pneumonia; Rhodococcus equi; Vaccination | 2021 |
2 other study(ies) available for acetylglucosamine and Pneumonia
| Article | Year |
|---|---|
In Vitro Antiviral and Anti-Inflammatory Activities of
Topics: Acetylglucosamine; Adenoviridae; Anti-Inflammatory Agents; Antiviral Agents; COVID-19; Glucosamine; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Pneumonia; Respiratory Tract Infections; SARS-CoV-2; Virus Diseases | 2023 |
Demethylallosamidin, a chitinase inhibitor, suppresses airway inflammation and hyperresponsiveness.
Topics: Acetylglucosamine; Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemokine CCL11; Chitinases; Cyclooxygenase 2 Inhibitors; Down-Regulation; Interleukin-13; Lung; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Pneumonia; Trisaccharides | 2009 |